Fortis Healthcare seeks member approval for Mohd Shahazwan Bin Mohd Harris's director appointment
Fortis Healthcare is seeking member approval for the appointment of Mr. Mohd Shahazwan Bin Mohd Harris as a Non-Independent & Non-Executive Director. Voting will be conducted via postal ballot and e-voting from December 24, 2025, to January 22, 2026. Mr. Harris has over 25 years of experience in investments and strategy.
The appointment of a director is a standard governance procedure and typically has a minimal immediate impact on the company's operations or financial performance.
The announcement is a routine corporate action regarding the appointment of a director, which is standard procedure and does not inherently suggest positive or negative performance.
Fortis Healthcare Limited has initiated a postal ballot process to seek approval from its members for the appointment of Mr. Mohd Shahazwan Bin Mohd Harris (DIN: 08465456) as a Non-Independent & Non-Executive Director. The company is sending the postal ballot notice to its members on December 23, 2025. Mr. Harris was appointed as an Additional Director effective December 19, 2025, and is liable to retire by rotation. Shareholders can cast their votes electronically via e-voting or by postal ballot. The remote e-voting period commences on December 24, 2025, at 9:00 a.m. IST and concludes on January 22, 2026, at 5:00 p.m. IST. Ballots received after this date will be considered invalid. Mr. Mukesh Agarwal has been appointed as the Scrutinizer to ensure a fair and transparent voting process. The result of the postal ballot will be declared on or before January 27, 2026.
Mr. Mohd Shahazwan Bin Mohd Harris, aged 54, brings extensive experience in investments, mergers and acquisitions, portfolio and asset management, and corporate strategy, with over 25 years in the field. He holds an MBA from MIT and degrees from Imperial College and the University of Warwick. He previously served as Advisor, Special Projects in UEM Group and was Head of Strategic Investments at the Employees Provident Fund (EPF). He also held senior roles at Tenaga Nasional Berhad, Khazanah Nasional Berhad, Bain & Co., and Temasek International Advisory, and is currently on the Advisory Board of Stashaway. He was appointed to the Board of IHH Healthcare Berhad in March 2023. The Nomination and Remuneration Committee and the Board of Directors have recommended his appointment.
What to do with a filing like this
Fortis Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under board meeting. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fortis Healthcare Limited. Read the original for the full detail.